Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Why Merck KGaA is spending $11.3bn on Bio-Techne instead of another drug pipeline Merck KGaA plans to acquire Bio-Techne for $11.3 billion. Read why laboratory tools, recurring revenue and debt-funded growth could reshape its strategy. bySrinathJuly 3, 2026